Oorsprong van het eerstegraads netwerk van Luis Manuel Sánchez Carlos
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Brace Pharmaceuticals, Inc.
 Brace Pharmaceuticals, Inc. Investment ManagersFinance Brace Pharmaceuticals, Inc (Brace Pharmaceuticals) is a venture capital firm founded in 2013. The firm is headquartered in Atlanta.
4
| Private Company | Investment Managers | 4 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Luis Manuel Sánchez Carlos via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | Founder | |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Pharmaceuticals: Other | Founder | |
The International Centre for Missing & Exploited Children
 The International Centre for Missing & Exploited Children Services to the Health IndustryHealth Services The International Centre for Missing & Exploited Children is an organization that focuses on finding missing children and protecting children from exploitation worldwide. The non-profit company is based in Alexandria, VA and the CEO of the company is Paul Shapiro. The company's work involves powering the search for missing children and implementing measures to safeguard children from harm. | Services to the Health Industry | Director/Board Member | |
| PRECISION BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
Vero Biotech LLC
 Vero Biotech LLC Pharmaceuticals: MajorHealth Technology Vero Biotech LLC is a biotechnology company, which focuses on the design, development and commercialization of inhaled nitric oxide delivery systems to address the unmet medical needs of patients with cardiopulmonary conditions. It develops a drug, GeNOsyl to meet the needs of patients and care providers. The company was founded by David H. Fine in 2006 and is headquartered in Atlanta, GA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Gliknik, Inc.
 Gliknik, Inc. Pharmaceuticals: MajorHealth Technology Gliknik, Inc. discovers and develops biotechnology drugs for autoimmune diseases and cancer. The company was founded by David S. Block and Scott E. Strome in 2007 and is headquartered in Baltimore, MD. | Pharmaceuticals: Major | Director/Board Member | |
Antiva Biosciences, Inc.
 Antiva Biosciences, Inc. BiotechnologyHealth Technology Antiva Biosciences, Inc. is a biopharmaceutical company developing novel, topical therapeutics for the treatment of diseases caused by HPV infection. The company was founded by Karl Y. Hostetler in 2012 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member | |
Navitor Pharmaceuticals, Inc.
 Navitor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Navitor Pharmaceuticals, Inc. develops medicine for age-related diseases. Its drug discovery platform targets mTORC1, which responds to and integrates the cell’s response to nutrient availability and plays a key role in protein synthesis and cellular growth. The company was founded by Alan L. Crane, David Sabatini and David Goldfarb and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| AVIDITY BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
| University of Bath | College/University | Doctorate Degree | |
| Emory University | College/University | Corporate Officer/Principal | |
| Georgia State University | College/University | Corporate Officer/Principal | |
| Princeton University | College/University | Undergraduate Degree | |
| University of Western Ontario | College/University | Undergraduate Degree | |
The American Foundation For AIDS Research, Inc.
 The American Foundation For AIDS Research, Inc. Miscellaneous Commercial ServicesCommercial Services The American Foundation For AIDS Research, Inc. provides research services. It plays a role in AIDS research, identifying critical gaps in their knowledge of HIV and AIDS. The company was founded in 1985 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member | |
| University of Innsbruck | College/University | Masters Business Admin | |
Interward Asset Management Ltd.
 Interward Asset Management Ltd. Investment ManagersFinance Interward Asset Management, Ltd. (IAML) is a Canadian multi-family office headquartered in Toronto, Ontario. The firm was founded by Kim Ward in 1990. IAML serves a discrete number of high-net-worth clients focused on private and public equities. | Investment Managers | Analyst-Equity | |
TrioBiotics Pharma AG
 TrioBiotics Pharma AG Pharmaceuticals: MajorHealth Technology TrioBiotics Pharma AG manufactures pharmaceuticals for the treatment of psychiatric, cancer and infectious diseases. It offers anti-infectives for chronic and infectious disease markets. The company is headquartered in Zurich, Switzerland. | Pharmaceuticals: Major | Chairman | |
RFS Pharma LLC
 RFS Pharma LLC Pharmaceuticals: MajorHealth Technology Part of Cocrystal Pharma, Inc., RFS Pharma LLC develops novel medicines for use in the treatment of human viral diseases. The company is based in Tucker, GA. RFS Pharma was acquired by Cocrystal Pharma, Inc. on November 25, 2014. The company was founded by Raymond F. Schinazi. | Pharmaceuticals: Major | Founder | |
Daiichi Sankyo, Inc.
 Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | Pharmaceuticals: Major | Private Equity Investor | |
Tyrogenex, Inc.
 Tyrogenex, Inc. Pharmaceuticals: MajorHealth Technology Tyrogenex, Inc. operates as a biopharmaceutical company which develops dual vascular endothelial growth factor receptor and platelet-derived growth factor receptor inhibitors for wet age-related macular degeneration and solid tumors. Its compound targets the basic mechanisms of neovascular eye diseases, including angiogenesis, fibrosis and inflammation. The company was founded by Chris Liang, Teri Ardleigh Swift, and Sheridan G. Snyder and is headquartered in Rockville, MD. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Global Virus Network
 Global Virus Network Miscellaneous Commercial ServicesCommercial Services Global Virus Network conducts research on essential and critical defense against viral diseases. The non-profit company is based in Baltimore, MD. The company was founded by William Walmsley Hall and Robert C. Gallo. | Miscellaneous Commercial Services | Director/Board Member | |
| The Schulich School of Business | College/University | Masters Business Admin | |
| COCRYSTAL PHARMA, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| Center for Aids Research At Emory University | Corporate Officer/Principal | ||
ReViral Ltd.
 ReViral Ltd. BiotechnologyHealth Technology ReViral Ltd. specializes in the areas of virology and antiviral therapies. It offers drugs to treat respiratory synctial virus infection. The company was founded by Neil Matthews and Stuart Cockerill in 2011 and is headquartered in Stevenage, the United Kingdom. | Biotechnology | Director/Board Member | |
| VIRIDIAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Petrichor Healthcare Capital Management LP
 Petrichor Healthcare Capital Management LP Investment ManagersFinance Petrichor Healthcare Capital Management LP (Petrichor) is a private equity firm founded in 2016 by Tadd Wessel. The firm headquartered in New York. | Investment Managers | Consultant / Advisor | |
HotSpot Therapeutics, Inc.
 HotSpot Therapeutics, Inc. BiotechnologyHealth Technology HotSpot Therapeutics, Inc. develops new allosteric therapies with the ability to treat disease. The company was founded by Jonathan Montagu and Geraldine Harriman and is headquartered in Boston, MA. | Biotechnology | Director/Board Member | |
| CONTINEUM THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| Vero Biotech, Inc. | Director/Board Member | ||
| University At Buffalo | College/University | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 29 |
| Canada | 4 |
| Verenigd Koninkrijk | 3 |
| Oostenrijk | 2 |
| Zwitserland | 2 |
Sectoraal
| Health Technology | 20 |
| Consumer Services | 9 |
| Commercial Services | 4 |
| Finance | 3 |
| Health Services | 2 |
Operationeel
| Director/Board Member | 26 |
| Chairman | 4 |
| Independent Dir/Board Member | 4 |
| Founder | 4 |
| Private Equity Investor | 4 |
Sterkste connecties
| Insiders | |
|---|---|
| Raymond Schinazi | 19 |
| Todd Brady | 15 |
| Vinzenz Ploerer | 7 |
| Daniel Salazar | 5 |
- Beurs
- Insiders
- Luis Manuel Sánchez Carlos
- Bedrijfsconnecties
